Market Cap : 1.79 B | Enterprise Value : 1.54 B | PE Ratio : | PB Ratio : 5.06 |
---|
NAS:TVTX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:TVTX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2021-02-25), Travere Therapeutics's share price is $29.950000. Travere Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2020 was $-0.79. Hence, Travere Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .
Travere Therapeutics's Cash Flow from Operations per share for the three months ended in Sep. 2020 was $0.13. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2020 was $-0.79.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Travere Therapeutics's Price-to-Operating-Cash-Flow falls into.
Travere Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as
Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
= | 29.950000 | / | -0.785 | |
= |
Travere Therapeutics's Share Price of today is $29.950000.
Travere Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2020 was -0.104 (Dec. 2019 ) + -0.669 (Mar. 2020 ) + -0.144 (Jun. 2020 ) + 0.132 (Sep. 2020 ) = $-0.79.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Price-to-Operating-Cash-Flow Ratio | = | Market Cap | / | Cash Flow from Operations |
No Headline